These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 18171296

  • 1. Interleukin-4-transgenic hu-PBL-SCID mice: a model for the screening of antiviral drugs and immunotherapeutic agents against X4 HIV-1 viruses.
    Okuma K, Tanaka R, Ogura T, Ito M, Kumakura S, Yanaka M, Nishizawa M, Sugiura W, Yamamoto N, Tanaka Y.
    J Infect Dis; 2008 Jan 01; 197(1):134-41. PubMed ID: 18171296
    [Abstract] [Full Text] [Related]

  • 2. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.
    Boyle MJ, Connors M, Flanigan ME, Geiger SP, Ford H, Baseler M, Adelsberger J, Davey RT, Lane HC.
    J Immunol; 1995 Jun 15; 154(12):6612-23. PubMed ID: 7759895
    [Abstract] [Full Text] [Related]

  • 3. Human immunodeficiency virus type 1 strains R5 and X4 induce different pathogenic effects in hu-PBL-SCID mice, depending on the state of activation/differentiation of human target cells at the time of primary infection.
    Fais S, Lapenta C, Santini SM, Spada M, Parlato S, Logozzi M, Rizza P, Belardelli F.
    J Virol; 1999 Aug 15; 73(8):6453-9. PubMed ID: 10400739
    [Abstract] [Full Text] [Related]

  • 4. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.
    Lapenta C, Santini SM, Proietti E, Rizza P, Logozzi M, Spada M, Parlato S, Fais S, Pitha PM, Belardelli F.
    Virology; 1999 Oct 10; 263(1):78-88. PubMed ID: 10544084
    [Abstract] [Full Text] [Related]

  • 5. Identification of HIV-1 epitopes that induce the synthesis of a R5 HIV-1 suppression factor by human CD4+ T cells isolated from HIV-1 immunized hu-PBL SCID mice.
    Yoshida A, Tanaka R, Kodama A, Yamamoto N, Ansari AA, Tanaka Y.
    Clin Dev Immunol; 2005 Dec 10; 12(4):235-42. PubMed ID: 16584108
    [Abstract] [Full Text] [Related]

  • 6. Pertussis toxin B-oligomer inhibits HIV infection and replication in hu-PBL-SCID mice.
    Lapenta C, Spada M, Santini SM, Racca S, Dorigatti F, Poli G, Belardelli F, Alfano M.
    Int Immunol; 2005 Apr 10; 17(4):469-75. PubMed ID: 15746245
    [Abstract] [Full Text] [Related]

  • 7. Cocaine and sigma-1 receptors modulate HIV infection, chemokine receptors, and the HPA axis in the huPBL-SCID model.
    Roth MD, Whittaker KM, Choi R, Tashkin DP, Baldwin GC.
    J Leukoc Biol; 2005 Dec 10; 78(6):1198-203. PubMed ID: 16204638
    [Abstract] [Full Text] [Related]

  • 8. Suppression of multiclade R5 and X4 human immunodeficiency virus type-1 infections by a coreceptor-based anti-HIV strategy.
    Nakayama D, Misumi S, Mukai R, Tachibana K, Umeda M, Shibata H, Takamune N, Shoji S.
    J Biochem; 2005 Nov 10; 138(5):571-82. PubMed ID: 16272569
    [Abstract] [Full Text] [Related]

  • 9. HIV hollow fiber SCID model for antiviral therapy comparison with SCID/hu model.
    Taggart BR, Harrington P, Hollingshead M.
    Antiviral Res; 2004 Jul 10; 63(1):1-6. PubMed ID: 15196814
    [Abstract] [Full Text] [Related]

  • 10. Glycosylphosphatidylinositol-Anchored Anti-HIV scFv Efficiently Protects CD4 T Cells from HIV-1 Infection and Deletion in hu-PBL Mice.
    Ye C, Wang W, Cheng L, Li G, Wen M, Wang Q, Zhang Q, Li D, Zhou P, Su L.
    J Virol; 2017 Feb 01; 91(3):. PubMed ID: 27881659
    [Abstract] [Full Text] [Related]

  • 11. SCID-hu mice: a model for studying disseminated HIV infection.
    Goldstein H, Pettoello-Mantovani M, Katopodis NF, Kim A, Yurasov S, Kollmann TR.
    Semin Immunol; 1996 Aug 01; 8(4):223-31. PubMed ID: 8883145
    [Abstract] [Full Text] [Related]

  • 12. Defining antibody protection against HIV-1 transmission in Hu-PBL-SCID mice.
    Koup RA, Safrit JT, Weir R, Gauduin MC.
    Semin Immunol; 1996 Aug 01; 8(4):263-8. PubMed ID: 8883150
    [Abstract] [Full Text] [Related]

  • 13. Raft localization of CXCR4 is primarily required for X4-tropic human immunodeficiency virus type 1 infection.
    Kamiyama H, Yoshii H, Tanaka Y, Sato H, Yamamoto N, Kubo Y.
    Virology; 2009 Mar 30; 386(1):23-31. PubMed ID: 19178925
    [Abstract] [Full Text] [Related]

  • 14. Differential susceptibility of human thymic dendritic cell subsets to X4 and R5 HIV-1 infection.
    Schmitt N, Nugeyre MT, Scott-Algara D, Cumont MC, Barré-Sinoussi F, Pancino G, Israël N.
    AIDS; 2006 Feb 28; 20(4):533-42. PubMed ID: 16470117
    [Abstract] [Full Text] [Related]

  • 15. Tetrahydrocannabinol suppresses immune function and enhances HIV replication in the huPBL-SCID mouse.
    Roth MD, Tashkin DP, Whittaker KM, Choi R, Baldwin GC.
    Life Sci; 2005 Aug 19; 77(14):1711-22. PubMed ID: 15964028
    [Abstract] [Full Text] [Related]

  • 16. Viral pathogenesis in hu-PBL-SCID mice.
    Mosier DE.
    Semin Immunol; 1996 Aug 19; 8(4):255-62. PubMed ID: 8883149
    [Abstract] [Full Text] [Related]

  • 17. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
    Waters L, Mandalia S, Randell P, Wildfire A, Gazzard B, Moyle G.
    Clin Infect Dis; 2008 May 15; 46(10):1617-23. PubMed ID: 18419499
    [Abstract] [Full Text] [Related]

  • 18. Moesin is required for HIV-1-induced CD4-CXCR4 interaction, F-actin redistribution, membrane fusion and viral infection in lymphocytes.
    Barrero-Villar M, Cabrero JR, Gordón-Alonso M, Barroso-González J, Alvarez-Losada S, Muñoz-Fernández MA, Sánchez-Madrid F, Valenzuela-Fernández A.
    J Cell Sci; 2009 Jan 01; 122(Pt 1):103-13. PubMed ID: 19066282
    [Abstract] [Full Text] [Related]

  • 19. High frequency of X4/DM-tropic viruses in PBMC samples from patients with primary HIV-1 subtype-B infection in 1996-2007: the French ANRS CO06 PRIMO Cohort Study.
    Frange P, Galimand J, Goujard C, Deveau C, Ghosn J, Rouzioux C, Meyer L, Chaix ML.
    J Antimicrob Chemother; 2009 Jul 01; 64(1):135-41. PubMed ID: 19411680
    [Abstract] [Full Text] [Related]

  • 20. Cocaine enhances human immunodeficiency virus replication in a model of severe combined immunodeficient mice implanted with human peripheral blood leukocytes.
    Roth MD, Tashkin DP, Choi R, Jamieson BD, Zack JA, Baldwin GC.
    J Infect Dis; 2002 Mar 01; 185(5):701-5. PubMed ID: 11865430
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.